Article
Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients.
Journal of thrombosis and thrombolysis - 1 Jul 2012
Liang Ruijuan, Li Lei, Li Cuilan, Gao Yuanfeng, Liu Wenling, Hu Dayi, Sun Yihong
Abstract excerpt
To evaluate the impact of gene polymorphisms of Cytochrome P450 2C9 (CYP2C9), Vitamin K epoxide reductase complex subunit 1 (VKORC1) and Cytochrome P450 4F2 (CYP4F2) and clinical factors on warfarin maintenance dose in Han-Chinese patients from main land. DNA was extracted from 115 patients taking warfarin for more than 3 months with a stable international normalized ratio (INR) and genotyped for CYP2C9*3,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
